Skip to main content
Figure 2 | BMC Urology

Figure 2

From: Effects of tadalafil treatment after bilateral nerve-sparing radical prostatectomy: quality of life, psychosocial outcomes, and treatment satisfaction results from a randomized, placebo-controlled phase IV study

Figure 2

Summary of treatment group differences between tadalafil OaD and tadalafil PRN versus placebo at the end of DBT and OLT. aFor men ≤ 60 years and 61–68 years, the overall treatment effect presented includes all visits from baseline to end of OLT. Data are from MMRM models, including baseline value (except for EDITS), treatment, country, visit, visit-by-treatment interaction, and age group (men ≤60 years, men 61–68 years). The MMRM assessing the combined sexual/incontinence score (post-hoc) additionally adjusted for body mass index, smoking status, nerve-sparing score, and type of surgery (open, conventional, robot-assisted, other). Age-group-by-treatment interaction was included in the models only if significant at the 10% level.

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us